SB 2308
Effective immediately
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
- Texas
- Senate
- Introduced Mar 11, 2025
- Session 89R
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Texas’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
73 actions-
Effective immediately
-
Signed by the Governor
-
Sent to the Governor
-
Signed in the House
-
Signed in the Senate
-
Reported enrolled
-
House adopts conf. comm. report-reported
-
Statement(s) of vote recorded in Journal
-
Record vote
-
House adopts conference committee report
-
House adopts resolution to go outside bounds
-
Senate adopts conf. comm. report-reported
-
Record vote
-
Senate adopts conference committee report
-
Senate adopts resolution to go outside bounds
-
Conf. Comm. Report distributed
-
Conference committee report filed
-
House appoints conferees-reported
-
House grants request for conf comm-reported
-
House appoints conferees
-
House grants request for conference committee
-
Senate appoints conferees-reported
-
Senate requests conference committee-reported
-
Senate refuses to concur-reported
-
Senate appoints conferees
-
Senate requests conference committee
-
Senate refuses to concur
-
Read
-
House amendment(s) laid before the Senate
-
House passage as amended reported
-
Statement(s) of vote recorded in Journal
-
Record vote
-
Passed
-
Read 3rd time
-
Statement(s) of vote recorded in Journal
-
Record vote
-
Passed to 3rd reading as amended
-
Amended
-
Read 2nd time
-
Laid out in lieu of companion
-
Committee report sent to Calendars
-
Committee report distributed
-
Comte report filed with Committee Coordinator
-
Reported favorably as substituted
-
Committee substitute considered in committee
-
Considered in formal meeting
-
Referred to Public Health
-
Read first time
-
Received from the Senate
-
Reported engrossed
-
Record vote
-
Passed
-
Read 3rd time
-
Record vote
-
Three day rule suspended
-
Record vote
-
Read 2nd time & passed to engrossment
-
Record vote
-
Rules suspended-Regular order of business
-
Placed on intent calendar
-
Co-author authorized
-
Committee report printed and distributed
-
Reported favorably w/o amendments
-
Vote taken in committee
-
Considered in public hearing
-
Left pending in committee
-
Testimony taken in committee
-
Considered in public hearing
-
Scheduled for public hearing on . . .
-
Referred to Health & Human Services
-
Read first time
-
Filed
-
Received by the Secretary of the Senate